Skip to main content
Log in

Urinary pseudouridine excretion in myelomatosis

  • Original Article
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Urinary psi excretion is independent of the main indices of tumour activity in myelomatosis (serum paraprotein, serum beta 2-microglobulin, serum creatinine and urinary light chain production). The mean (+/- s.d.) psi at presentation was 40.7 +/- 22.6 nmol. mumol ucr-1, compared to 25.4 +/- 4.8 nmol. mumol ucr-1 in controls. Urinary psi levels at presentation are significantly related to prognosis, the higher the level the poorer the prognosis. However, when these levels have been stratified according to the corresponding level of serum beta 2m, the level adds little as a prognostic factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sørensen, S., Brown, D., Cooper, E. et al. Urinary pseudouridine excretion in myelomatosis. Br J Cancer 52, 863–866 (1985). https://doi.org/10.1038/bjc.1985.270

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1985.270

  • Springer Nature Limited

Navigation